Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 486)
Posted On: 09/29/2024 10:41:35 PM
Post# of 154090
Posted By: My69z
Remember Gilead’s Twice-Yearly Lenacapavir for HIV caused a rush of questions towards Cytodyn's positioning?

Lenacapavir's profile:
Lenacapavir Interactions
There are 460 drugs known to interact with lenacapavir, along with 2 disease interactions. Of the total drug interactions, 62 are major, 387 are moderate, and 11 are minor.

https://www.drugs.com/drug-interactions/lenacapavir.html
________

Cytodyns' profile:
A no SAE, Leronlimab-PLS, that binds to FrNc, 100% mom & child CCR5 RO, Placenta(s).

If that isn't a hold my beer "response", I don't know what is.

Not to mention twins, triplets, etc....
















(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site